The Schwab U.S. Dividend Equity ETF just completed its annual reconstitution and rebalance. This event is typically watched very closely as it can result in some major changes to the popular ETF's ...

Some of us have a medicine cabinet that looks less like a pharmacy and more like a museum. It’s why I make a point to do an inventory at least once a year with my spring cleaning. You never know what ...

The Schwab U.S. Dividend Equity ETF will complete its annual reconstitution in March. It's not unusual to see 15-20 names change in the 100-stock portfolio. I expect to see an increase in financials, ...

While the primary focus of this blog will be skills training and targeting problems with psychodynamic psychotherapy (Busch, 2022), I thought it would be useful to begin with a discussion about how ...

The U.S. and its allies have spilled blood and treasure to kill drug lords and defeat cartels, but the drugs keep coming and the new groups are more violent than ever. By Maria Abi-Habib Reporting ...

I last analyzed the Schwab US Dividend Equity ETF (SCHD) on January 15, with an article entitled “SCHD Vs. SPY: Rotation To Value Is Gaining Momentum.” The article was triggered by the divergence I ...

Food and Drug Administration Commissioner Marty Makary told CNBC that his view is that "everything should be over the counter" unless a drug is unsafe, addictive or requires monitoring. He said the ...

The Trump administration finally has unveiled TrumpRx.gov, a website for consumers to find discounts on brand-name drugs if they pay cash instead of using their health insurance. It launched Thursday ...

President Donald Trump put his personal stamp Thursday night on a new government website, TrumpRx, aimed at helping Americans buy medicines at lower prices. "This is a very big deal," Trump said Feb.

Doctors often prescribe multiple medications to target different biological systems at the same time, which is more effective at lowering blood pressure than simply increasing the dose of a single ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...